Literature DB >> 11502510

Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.

P Margolis1, C Hackbarth, S Lopez, M Maniar, W Wang, Z Yuan, R White, J Trias.   

Abstract

Resistance to peptide deformylase inhibitors in Escherichia coli or Staphylococcus aureus is due to inactivation of transformylase activity. Knockout experiments in Streptococcus pneumoniae R6x indicate that the transformylase (fmt) and deformylase (defB) genes are essential and that a def paralog (defA) is not. Actinonin-resistant mutants of S. pneumoniae ATCC 49619 harbor mutations in defB but not in fmt. Reintroduction of the mutated defB gene into wild-type S. pneumoniae R6x recreates the resistance phenotype. The altered enzyme displays decreased sensitivity to actinonin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502510      PMCID: PMC90673          DOI: 10.1128/AAC.45.9.2432-2435.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents.

Authors:  C Giglione; M Pierre; T Meinnel
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform.

Authors:  J P Claverys; A Dintilhac; E V Pestova; B Martin; D A Morrison
Journal:  Gene       Date:  1995-10-16       Impact factor: 3.688

3.  Evolutionary families of metallopeptidases.

Authors:  N D Rawlings; A J Barrett
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Formate dehydrogenase-coupled spectrophotometric assay of peptide deformylase.

Authors:  C Lazennec; T Meinnel
Journal:  Anal Biochem       Date:  1997-01-01       Impact factor: 3.365

5.  Marker discrimination in transformation and mutation of pneumococcus.

Authors:  J G Tiraby; M S Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

6.  Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

Authors:  C Apfel; D W Banner; D Bur; M Dietz; T Hirata; C Hubschwerlen; H Locher; M G Page; W Pirson; G Rossé; J L Specklin
Journal:  J Med Chem       Date:  2000-06-15       Impact factor: 7.446

7.  Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase.

Authors:  T Meinnel; S Blanquet
Journal:  J Bacteriol       Date:  1994-12       Impact factor: 3.490

8.  A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase.

Authors:  T Meinnel; S Blanquet; F Dardel
Journal:  J Mol Biol       Date:  1996-09-27       Impact factor: 5.469

9.  Mapping of the active site zinc ligands of peptide deformylase.

Authors:  T Meinnel; C Lazennec; S Blanquet
Journal:  J Mol Biol       Date:  1995-11-24       Impact factor: 5.469

10.  Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation.

Authors:  D Mazel; S Pochet; P Marlière
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  29 in total

1.  Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae.

Authors:  Pan F Chan; Karen M O'Dwyer; Leslie M Palmer; Jennifer D Ambrad; Karen A Ingraham; Chi So; Michael A Lonetto; Sanjoy Biswas; Martin Rosenberg; David J Holmes; Magdalena Zalacain
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

Review 2.  Determination of the core of a minimal bacterial gene set.

Authors:  Rosario Gil; Francisco J Silva; Juli Peretó; Andrés Moya
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

3.  Identification of regions involved in enzymatic stability of peptide deformylase of Mycobacterium tuberculosis.

Authors:  Rahul Saxena; Pradip K Chakraborti
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

4.  Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes.

Authors:  Annika I Nilsson; Anna Zorzet; Anna Kanth; Sabina Dahlström; Otto G Berg; Dan I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

5.  Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.

Authors:  Charles R Dean; Shubha Narayan; Joel Richards; Denis M Daigle; Stacy Esterow; Jennifer A Leeds; Heather Kamp; Xiaoling Puyang; Brigitte Wiedmann; Dieter Mueller; Hans Voshol; Jan van Oostrum; Daniel Wall; James Koehn; Joann Dzink-Fox; Neil S Ryder
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

6.  Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.

Authors:  Klaudia Kosowska-Shick; Kim L Credito; Glenn A Pankuch; Bonifacio DeWasse; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

7.  Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.

Authors:  Yann Duroc; Carmela Giglione; Thierry Meinnel
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

8.  Activity of LBM415 compared to those of 11 other agents against Haemophilus species.

Authors:  Tatiana Bogdanovich; Kathy A Smith; Catherine Clark; Glenn A Pankuch; Gengrong Lin; Pamela McGhee; Bonifacio Dewasse; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

9.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.

Authors:  Ruth E Caughlan; Shubha Sriram; Denis M Daigle; Angela L Woods; Jennifer Buco; Ron L Peterson; Joann Dzink-Fox; Susan Walker; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.